Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Morepen Laboratories Ltd.

NSE: MOREPENLAB | BSE:500288

₹55.82 -0.36 (-0.64%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

55.50

Today’s High

57.00

52W low

28.60

52W High

59.80

Open Price

56.50

Prev. Close

47.7000

Volume

4601371.00

Value

256848529.22

Fundamentals

Market Cap Cr

2853.30

Price to Earnings

29.70

Price to Book Value

3.40

Dividend Yield

0.00

PE to Growth

0.20

Op Revenue TTM Cr

1690.43

Net Profit TTM Cr

96.16

Cash From Operating Activity Cr

73.37

Return on Equity %

11.34

EMA & SMA

Bullish Moving Averages

14

Bearish Moving Averages

2

5Day EMA

56.1

10Day EMA

55.5

12Day EMA

55.2

20Day EMA

53.9

26Day EMA

53.2

50Day EMA

51.2

100Day EMA

49.1

200Day EMA

45.7

5Day SMA

56.4

10Day SMA

55.7

20Day SMA

53.8

30Day SMA

51.5

50Day SMA

50.2

100Day SMA

48.9

150Day SMA

48.5

200Day SMA

45.6

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

04 Jul, 2024

39.9

Week

30.3

Month

33.4

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

56.10

PIVOT

First Resistance

56.68

Second Resistance

57.55

Third Resistance

58.13

First Support

55.23

Second Support

54.65

Third Support

53.78

Relative Strength Index

58.61

Money Flow Index

72.22

MACD

2.06

MACD Signal

2

Average True Range

2.48

Average Directional Index

28.49

Rate of Change (21)

28.77

Rate of Change (125)

13.46

Commodity Channel Index

54.6

Williams %R

-50.2

BETA

1 Month

1.17

3 Month

1.05

1 Year

1.06

3 Year

0.41

PRICE CHANGE ANALYSIS

↑ 0.52%

1 Week

Low

High

52.98

59.8

↑ 19.4%

1 Month

Low

High

42.05

59.8

↑ 15.45%

3 Months

Low

High

42.05

59.8

↑ 8.92%

6 Months

Low

High

38.55

59.8

↑ 84.53%

1 Year

Low

High

28.6

59.8

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 396.59 398.29 384.10 371.19 339.51 345.81 384.22 275.11 345.55 374.89 372.24
Operating Expenses Qtr 336.46 343.52 351.50 344.30 321.39 323.17 356.26 260.79 323.26 341.72 332.56
Operating Profit Qtr 56.14 51.12 29.76 24.80 15.13 21.45 27.08 13.61 19.18 30.49 36.83
EBIDT Qtr Cr 60.12 54.77 32.60 26.89 18.12 22.63 27.96 14.32 22.29 33.18 39.68
Depreciation Qtr 6.69 5.51 4.81 4.89 4.61 4.56 4.46 4.37 4.82 5.28 5.70
Net Profit Qtr 39.96 35.20 19.92 15.85 10.28 12.57 16.52 6.88 14.27 21.51 34.43
Basic EPS Qtr 0.78 0.69 0.39 0.31 0.20 0.23 0.35 0.14 0.32 0.48 0.77
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 1550.16 1344.64 1459.50 1124.20 801.40
Operating Expenses Annual Cr 1375.77 1261.61 1320.13 1000.05 727.52
Operating Profit Annual 161.82 77.27 129.14 112.37 64.47
Operating Profit Margin Annual % 10.44 5.75 8.85 10.00 8.04
Total Expenses Annual Cr 1401.18 1281.60 1333.96 1029.95 763.92
EBIDT Annual Cr 174.38 83.03 139.37 124.15 73.88
EBIDT Annual margin % 11.25 6.17 9.55 11.04 9.22
Depreciation 21.90 18.01 21.19 28.11 34.43
PAT Before ExtraOrdinary Items Annual Cr 110.94 46.24 101.06 94.25 32.33
Net Profit Annual 110.94 46.24 101.06 94.25 32.33
Basic EPS Annual 2.17 0.92 2.25 2.10 0.72
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 889.02 780.11 598.17 401.22 307.25
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 37.65 34.45 32.41 26.89 25.36
Total Current Liabilities Annual Cr 352.63 290.98 402.69 375.63 329.38
Total Capital Plus Liabilities Annual Cr 1279.31 1105.54 1033.26 847.50 661.99
Fixed Assets Annual 240.99 187.83 170.26 145.98 134.84
Total Non Current Assets Annual 436.40 374.69 356.50 354.71 313.73
Total Current Assets Annual 842.91 730.85 676.76 492.79 348.26
Total Assets Annual 1279.31 1105.54 1033.26 847.50 661.99
Contingent Liabilities plus Commitments Annual Cr - 11.84 18.98 3.36 1.26
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 77.36 -102.12 -66.38 49.31 10.86
Cash from Investing Activity Annual -83.60 -36.20 -22.64 -69.09 -12.08
Cash from Financing Annual Activity 0.28 144.20 63.93 47.46 4.65
Net Cash Flow Annual - 5.88 -25.09 27.68 3.43
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 17.39 15.26 12.52 8.92 6.83
ROE Annual % 12.47 5.92 16.89 23.49 10.52
ROCE Annual % 16.45 7.98 18.74 20.35 11.86
Total Debt to Total Equity Annual 0.03 0.03 0.03 0.04 0.04
EBDIT Annual Margin % 11.34 6.20 9.61 11.16 9.32
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 427.32 448.62 425.01 403.46 366.81 349.69 403.85 303.31 371.46 399.19 398.17
Operating Expenses Qtr 374.69 393.99 388.18 374.95 348.13 327.95 374.07 287.86 349.61 364.38 353.29
Operating Profit Qtr 48.38 50.57 33.59 26.09 15.56 20.52 28.91 14.55 18.68 32.12 42.03
EBIDT Qtr Cr 52.62 54.64 36.83 28.51 18.68 21.74 29.78 15.46 21.85 34.81 44.88
Depreciation Qtr 9.62 8.45 7.69 7.71 6.98 7.19 7.00 6.76 6.88 6.93 7.14
Net Profit Qtr 28.28 31.99 21.26 14.63 8.24 8.99 15.81 5.63 12.32 21.52 37.36
Basic EPS Qtr 0.54 0.63 0.42 0.29 0.16 0.15 0.33 0.12 0.27 0.48 0.83
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 1704.40 1423.66 1557.13 1200.13 862.55
Operating Expenses Annual Cr 1531.81 1338.00 1410.15 1069.54 784.55
Operating Profit Annual 158.62 79.53 136.67 118.51 68.51
Operating Profit Margin Annual % 9.31 5.59 8.78 9.88 7.94
Total Expenses Annual Cr 1568.99 1367.91 1430.43 1101.61 823.44
EBIDT Annual Cr 172.60 85.67 146.98 130.58 78.00
EBIDT Annual margin % 10.13 6.02 9.44 10.88 9.04
Depreciation 33.47 27.93 27.64 30.28 36.91
PAT Before ExtraOrdinary Items Annual Cr 96.62 38.68 101.68 97.09 33.58
Net Profit Annual 96.16 38.68 101.68 97.09 33.58
Basic EPS Annual 1.88 0.77 2.26 2.16 0.75
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 847.23 752.91 578.56 424.75 284.06
Minority Interest Liability Annual Cr 0.00 -0.46 -0.46 -0.46 -0.46
Total Non Current Liabilities Annual Cr 43.93 36.88 35.50 30.06 28.42
Total Current Liabilities Annual Cr 402.04 321.16 456.46 403.80 351.44
Total Capital Plus Liabilities Annual Cr 1293.21 1110.50 1070.05 858.15 663.46
Fixed Assets Annual 257.32 209.51 191.47 152.01 141.90
Total Non Current Assets Annual 404.16 354.33 335.75 331.36 291.29
Total Current Assets Annual 889.04 756.16 734.30 526.79 372.18
Total Assets Annual 1293.21 1110.50 1070.05 858.15 663.46
Contingent Liabilities plus Commitments Annual Cr - 11.84 20.62 3.36 1.26
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 73.37 -91.17 -57.76 50.83 11.02
Cash from Investing Activity Annual -83.30 -46.51 -31.68 -70.35 -12.46
Cash from Financing Annual Activity 5.20 143.54 63.85 47.27 5.49
Net Cash Flow Annual - 5.86 -25.58 27.75 4.04
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 16.58 14.72 12.10 9.43 6.30
ROE Annual % 11.34 5.13 17.57 22.85 11.82
ROCE Annual % 15.61 7.31 19.44 22.07 13.16
Total Debt to Total Equity Annual 0.03 0.03 0.03 0.04 0.04
EBDIT Annual Margin % 10.21 6.04 9.50 10.99 9.14
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
SUSHIL SURI 1.08 75061551 0 0
ANJU SURI 1.01 75061552 0 0
SONIA PANKAJ BAJAJ 0.72 75061553 0 0
SANJAY SURI 0.67 75061554 0 0
SUNITA SURI 0.62 75061555 0 0
VARUN SURI 0.6 75061556 0 0
MAMTA SURI 0.59 75061557 0 0
SCOPE CREDITS AND FINANCIAL SERVICES PVT. LTD. 3.05 75061576 0 22.47
CONCEPT CREDITS AND CONSULTANTS PVT. LTD. 3 75061577 0 22.8
BROOK INVESTMENTS AND FINANCIAL SERVICES PVT. LTD. 2.97 75061578 0 23.09
SOLITARY INVESTMENTS AND FINANCIAL SERVICES PVT. LTD. 2.96 75061579 0 23.16
SOLACE INVESTMENTS AND FINANCIAL SERVICES PVT. LTD. 2.95 75061580 0 23.21
MID MED FINANCIAL SERVICES AND INVESTMENTS PVT. LTD. 2.93 75061581 0 23.37
REACT INVESTMENTS AND FINANCIAL SERVICES PVT. LTD. 2.92 75061582 0 23.42
EPITOME HOLDINGS PVT.LTD. 2.84 75061583 0 24.14
SEED SECURITIES AND SERVICES PVT. LTD. 2.8 75061584 0 24.43
SQUARE INVESTMENTS AND FINANCIAL SERVICES PVT. LTD. 2.76 75061585 0 24.82
LIQUID HOLDINGS PVT. LTD. 0.98 75061586 0 99.94
Name Holding Percent Holding Id
Name Holding Percent Holding Id
MOREPEN LABORATORIES LIMITED [UNCALIMED SHARES] 1.04 75061599
PINFOLD OVERSEAS LIMITED 7.54 75061604
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 18, 2002 - FINAL - Equity Share
Sep 03, 2001 - FINAL - Equity Share
Jan 24, 2001 - INTERIM Feb 09, 2001 Equity Share
Aug 18, 2000 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Nov 07, 2000 10:2 2000-11-22
Ex-Date Purpose Notes
May 21, 2024 Audited Results -
Jan 31, 2024 Quarterly Results -
Nov 02, 2023 Quarterly Results -
Aug 05, 2023 Quarterly Results -
May 16, 2023 Audited Results -
Feb 13, 2023 Quarterly Results -
Nov 10, 2022 Quarterly Results -
Jul 29, 2022 Quarterly Results -
May 05, 2022 Audited Results -
Feb 08, 2022 Quarterly Results & Others -
Nov 11, 2021 Quarterly Results -
Jul 27, 2021 Quarterly Results -
May 04, 2021 Audited Results -
Apr 28, 2021 Others Inter-alia, for raising of funds, through one or more modes including further public offer/ right issue/ preferential issue of equity shares/ warrants/ fully or partly convertible instruments
Feb 12, 2021 Quarterly Results -
Nov 09, 2020 Quarterly Results -
Oct 10, 2020 To consider raising of funds Inter alia, to consider and approve proposal for raising of funds, through one or more modes including further public offer/ right issue/ preferential issue
Aug 31, 2020 Quarterly Results -
Jun 22, 2020 Audited Results -
Feb 14, 2020 Quarterly Results -
Nov 13, 2019 Quarterly Results -
Sep 19, 2019 To consider raising of funds Inter alia, to consider and approve proposal for raising of funds, through one or more modes including further public offer/ right issue/ preferential issue.
Aug 13, 2019 Quarterly Results -
May 04, 2019 Audited Results -
Feb 04, 2019 Quarterly Results -
Nov 01, 2018 Quarterly Results -
Aug 13, 2018 Quarterly Results (Revised)
May 16, 2018 Audited Results -
Jan 22, 2018 Quarterly Results -
Nov 10, 2017 Quarterly Results -
Sep 11, 2017 Quarterly Results -
Apr 29, 2017 Audited Results -
Feb 08, 2017 Quarterly Results -
Nov 09, 2016 Quarterly Results -
Aug 09, 2016 Quarterly Results -
May 10, 2016 Audited Results -
Feb 08, 2016 Quarterly Results -
Nov 04, 2015 Quarterly Results Appointment of Ms. Archana Bhargava, as the Additional Director (Women Director) of the Company w.e.f. November 04, 2015.
Aug 07, 2015 Quarterly Results -
May 15, 2015 Audited Results -
Feb 11, 2015 Quarterly Results -
Nov 13, 2014 Quarterly Results -
Aug 09, 2014 Quarterly Results -
May 21, 2014 Audited Results -
May 19, 2014 Audited Results -
Feb 14, 2014 Quarterly Results -
Nov 13, 2013 Quarterly Results -
Aug 05, 2013 Quarterly Results -
May 13, 2013 Audited Results -
Feb 12, 2013 Quarterly Results -
Nov 05, 2012 Quarterly Results -
Aug 06, 2012 Quarterly Results -
May 14, 2012 Audited Results -
Feb 10, 2012 Quarterly Results -
Nov 09, 2011 Quarterly Results (Revised)
Aug 08, 2011 Quarterly Results -
May 13, 2011 Audited Results -
Feb 11, 2011 Quarterly Results -
Oct 30, 2010 Quarterly Results -
Jul 30, 2010 Quarterly Results -
May 13, 2010 Audited Results -
Jan 21, 2010 Quarterly Results -
Oct 27, 2009 Quarterly Results -
Aug 12, 2009 Allotment of Equity Shares The Board has made an allotment of 9,24,90,413 equity shares of Rs 2/- each to the Fixed Deposit holders of the Co., persuant to Scheme of Compromise & Arrangement, U/S 391-394 of Companies Act, 1956.
Jul 27, 2009 Quarterly Results -
May 26, 2009 Audited Results -
Jan 19, 2009 Quarterly Results -
Oct 22, 2008 Quarterly Results -
Jul 24, 2008 Quarterly Results -
May 15, 2008 Audited Results -
Jan 15, 2008 Quarterly Results -
Oct 18, 2007 Quarterly Results (Revised)
Jul 17, 2007 Quarterly Results -
Apr 30, 2007 Quarterly Results -
Mar 15, 2007 To consider issuance of Equity Shares To consider issuance of Equity Shares / Securities / Warrants to Investors, Banks and Financial Institutions on Preferential allotment basis.
Jan 31, 2007 Quarterly Results -
Oct 30, 2006 Quarterly Results -
Jul 28, 2006 Accounts & Quarterly Results Accounts for the Year ending 31-03-2006 (Revised)
Apr 27, 2006 Quarterly Results -
Jan 30, 2006 Quarterly Results -
Oct 27, 2005 Quarterly Results -
Jul 21, 2005 Quarterly Results & Others To consider allotment of 90,00,000 equity shares pursuant to the rights attached to the warrants.
Jun 30, 2005 Accounts (Revised)
Jan 22, 2005 Quarterly Results -
Oct 28, 2004 Quarterly Results -
Jul 29, 2004 Quarterly Results (Revised)
May 18, 2004 Others To consider the allotment of warrents/shares to promoters group.
Apr 30, 2004 Quarterly Results & Others Scheme of Arrangement
Feb 26, 2004 General To consider the warrants to promoters of the Company.
Jan 12, 2004 Quarterly Results -
Dec 24, 2003 Accounts (Revised)
May 13, 2003 Quarterly Results (Revised)
Mar 30, 2003 Others Allotment of GDRs including the underlying 50 million equity shares of Rs.2/- each.
Jan 29, 2003 Quarterly Results -
Oct 14, 2002 Quarterly Results -
Jul 29, 2002 Quarterly Results -
Jun 28, 2002 Accounts & Dividend -
Jan 18, 2002 Quarterly Results -
Oct 29, 2001 Quarterly Results -
Jul 27, 2001 Quarterly Results -
Jun 14, 2001 Accounts & Dividend -
Apr 16, 2001 Others Allotment of Forfeited Shares (announed on 11/04/2001)
Jan 08, 2001 Quarterly Results -
Oct 30, 2000 Quarterly Results -
Jul 15, 2000 Quarterly Results & Final Dividend -
Apr 28, 2000 Accounts & Dividend -
Feb 08, 2000 Private Placement -
Jan 29, 2000 Quarterly Results -
Oct 30, 1999 Quarterly Results -
Jul 29, 1999 Quarterly Results -
Jan 29, 1999 Quarterly Results -
Oct 29, 1998 Quarterly Results -
May 21, 1998 Accounts -
Nov 11, 1997 Half Yearly Results. -
May 30, 1997 Half Yearly Results. -
Ex-Date Bonus Ratio Record Date
Bigul
03 Jul 2024

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find attached intimation of loss of share certificates
Bigul
29 Jun 2024

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find attached intimation of loss of share certificate
Bigul
29 Jun 2024

MOREPEN LABORATORIES LTD. - 500288 - Closure of Trading Window

 Please find attached intimation of closure of trading window w.e.f., 1st July 2024 till 48 hours from the dissemination/ announcement of unaudited financial results for the quarter ended 30th June 2024.
Bigul
26 Jun 2024

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find attached intimation of issuance of duplicate share certificates
Bigul
20 Jun 2024

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find attached intimation of loss of share certificates
Bigul
19 Jun 2024

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find attached letter of confirmation for issuance of duplicate share certificates
Bigul
12 Jun 2024

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find attached issuance of letter of confirmation against duplicate share certificates
Bigul
12 Jun 2024

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find attached intimation of loss of share certificate
Bigul
05 Jun 2024

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find attached issuance of letter of confirmation against duplicate share certificates
Bigul
05 Jun 2024

MOREPEN LABORATORIES LTD. - 500288 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Please find attached intimation of loss of share certificates
See all News

FAQs

The latest market price of Morepen Laboratories Ltd. on NSE was Rs. 55.82 as of today.

The opening share price of Morepen Laboratories Ltd. was Rs. 56.50 as of today.

The 52-week high share price of Morepen Laboratories Ltd. was Rs. 59.80.

The 52 week low share price of Morepen Laboratories Ltd. was Rs. 28.60.

Morepen Laboratories Ltd. has a market cap of Rs. 2853.30 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Morepen Laboratories Ltd. is 0.20. Please refer to the Fundamentals section for further details.

The operating revenue for Morepen Laboratories Ltd. in the last FY was Rs.  1690.43 crore. Please refer to the Financials section for further details.

The Net Profit for Morepen Laboratories Ltd. in the last FY was Rs. 96.16 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

The latest split issue declared by Morepen Laboratories Ltd. was as of 2000-11-07. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Morepen Laboratories Ltd..

Close

Let's Open Free Demat Account